
Highlights from iwMyeloma 2025: trial updates and practical considerations
VJHemOnc Podcast
00:00
Advancements in Myeloma Treatment
This chapter explores the latest updates on antibody-drug conjugates, specifically Belantimab Mafodotin, and its role in treating multiple myeloma. It discusses the evolving landscape of bispecific therapies, upcoming FDA approvals, and the impact of new technologies on disease classification and treatment optimization.
Transcript
Play full episode